Thyroid-stimulating hormone (TSH) is associated with 30-day mortality in hip fracture patients.

Etienne Rapacki Jes Bruun Lauritzen Christian Medom Madsen Henrik Løvendahl Jørgensen Debbie Norring-Agerskov

Published in: European journal of trauma and emergency surgery : official publication of the European Trauma Society (2019)

The study demonstrates increased 30-day mortality in surgically treated hip fracture patients with plasma TSH levels above the median (1.41 mIU/L) at admission, even after adjusting for age, sex and CCI.

Keyphrases

hip fracture
end stage renal disease
newly diagnosed
cardiovascular events
ejection fraction
chronic kidney disease
emergency department
peritoneal dialysis
risk factors
prognostic factors